Found: 4
Select item for more details and to access through your institution.
Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 113, doi. 10.2147/PGPM.S160763
- By:
- Publication type:
- Article
Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2018, v. 11, p. 43, doi. 10.2147/PGPM.S157111
- By:
- Publication type:
- Article
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2017, v. 10, p. 209, doi. 10.2147/PGPM.S140700
- By:
- Publication type:
- Article
The correlation between CYP2D6 isoenzyme activity and haloperidol efficacy and safety profile in patients with alcohol addiction during the exacerbation of the addiction.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2016, v. 9, p. 89, doi. 10.2147/PGPM.S110385
- By:
- Publication type:
- Article